Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

It’s no secret that running, walking and cardio workouts can take a toll on your body. However, as somebody who loves to run marathons and also has arthritis, I can attest that once you find a pair of ...

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...

Side hustles have always held us down. They’ve been part of our mutual and collective economic survival long before the term ever became trendy. The moms who did hair on the side in the kitchen. The ...

Systems like OpenAI’s GPT-5 are accelerating research in math, biology and chemistry. But there is a debate over whether it can do that work on its own. Credit...Agnes Jonas Supported by By Cade Metz ...

A WIRED review of outputs hosted on Grok’s official website shows it’s being used to create violent sexual images and videos, as well as content that includes apparent minors. Unlike on X, where ...

You might be familiar with how Python and C can work together, by way of projects like Cython. The new PythoC project has a unique twist on working with both languages: it lets you write ...

PythoC lets you use Python as a C code generator, but with more features and flexibility than Cython provides. Here’s a first look at the new C code generator for Python. Python and C share more than ...